Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001542484-12-000001
Filing Date
2012-04-30
Accepted
2012-04-30 11:30:02
Documents
1
Period of Report
2011-12-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 11787
  Complete submission text file 0001542484-12-000001.txt   13361
Mailing Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075
Business Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075 858-433-2800
Imprimis Pharmaceuticals, Inc. (Issuer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1440 28TH STREET SUITE 9 BOULDER CO 80303
Business Address
Kammer Robert J (Reporting) CIK: 0001542484 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-52998 | Film No.: 12793039